MEDIMMUNE LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 10744
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 99157
 
  
 
C07D HETEROCYCLIC COMPOUNDS 39123
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 27140
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 2277
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1386
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 8198
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 5133
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5120
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 445

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0057,596 BINDING MEMBERS OF INTERLEUKIN-4 RECEPTOR ALPHA (IL4-Ra)Jan 24, 17Mar 01, 18[C07K]
2017/0290,920 ANTI-CD22 ANTIBODIES AND IMMUNOCONJUGATESApr 26, 17Oct 12, 17[A61K, C07D, C07K]
2017/0281,769 STABLE ANTI-IL-4Ra FORMULATIONSep 02, 15Oct 05, 17[A61K, C07K]
2017/0258,934 PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATESNov 25, 15Sep 14, 17[A61K, C07D, C07K]
2017/0260,276 TREATMENT FOR RHEUMATOID ARTHRITISMay 18, 15Sep 14, 17[A61K, C07K]
2017/0183,397 MULTI-SPECIFIC ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES AND USES THEREOFMay 04, 15Jun 29, 17[A61K, C07K]
2017/0174,756 STABILIZED ANGIOPOIETIN-2 ANTIBODIES AND USES THEREOFOct 27, 16Jun 22, 17[A61K, C07K]
2017/0166,634 ION CHANNEL MODULATORS AND USES THEREOFMay 02, 15Jun 15, 17[C07K]
2017/0129,955 ALPHA-V BETA-8 ANTIBODIESJun 17, 15May 11, 17[C07K]
2017/0101,468 HUMAN ANTI IL-6 ANTIBODIES WITH EXTENDED IN VIVO HALF-LIFE AND THEIR USE IN TREATMENT OF ONCOLOGY, AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASESDec 02, 16Apr 13, 17[C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9919056 Pyrrolobenzodiazepine-anti-CD22 antibody conjugatesOct 11, 13Mar 20, 18[A61K, C07K]
9889207 Pyrrolobenzodiazepines and conjugates thereofOct 11, 13Feb 13, 18[A61K, C07D]
9884902 CTLA-4 variantsMar 11, 13Feb 06, 18[A61K, C07K]
9884911 Compounds and methods for treating painFeb 02, 15Feb 06, 18[A61K, C07K]
9856317 Human antibody molecules for IL-13Mar 02, 16Jan 02, 18[C07H, A61K, C07K]
9834598 Antibodies to amyloid betaOct 15, 13Dec 05, 17[A61K, A61P, C07K]
9821074 Pyrrolobenzodiazepines and conjugates thereofMar 13, 14Nov 21, 17[A61K, C07D]
9796779 Binding proteins specific for insulin-like growth factors and uses thereofOct 06, 15Oct 24, 17[A61K, C12N, C07K]
9765130 Glucagon/GLP-1 agonists for the treatment of obesityDec 10, 13Sep 19, 17[A61K, C07K]
9745303 Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugationOct 11, 13Aug 29, 17[A61K, C07D, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0143,846 TARGETED PYRROLOBENZODIAZAPINE CONJUGATESAbandonedFeb 01, 17May 25, 17[A61K, C07K]
2016/0251,421 COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLT1 ANTAGONIST FOR TREATING CANCERAbandonedFeb 29, 16Sep 01, 16[A61K, C07K]
9387258 Pyrrolobenzodiazepines and targeted conjugatesWithdrawnOct 12, 12Jul 12, 16[A61K, C07D]
2016/0185,837 GIP AND GLP-1 RECEPTOR DUAL-AGONISTS FOR THE TREATMENT OF DIABETESAbandonedAug 15, 14Jun 30, 16[A61K, C07K]
2016/0129,108 THERAPEUTIC COMBINATIONS COMPRISING ANTI-CD73 ANTIBODIES AND USES THEREOFAbandonedNov 10, 15May 12, 16[A61K]
2016/0096,895 BINDING MEMBERS-513AbandonedOct 23, 15Apr 07, 16[C07K]
9266894 Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugatesWithdrawnSep 20, 12Feb 23, 16[A61K, C07D, C07K]
2015/0329,830 MYELOMA CELL CULTURE IN TRANSFERRIN-FREE LOW IRON MEDIUMAbandonedJul 22, 15Nov 19, 15[C12N]
2015/0284,450 COMBINATION THERAPIES USING ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULESAbandonedNov 06, 13Oct 08, 15[A61K, C07K]
2015/0239,970 Stable, Low Viscosity Antibody FormulationAbandonedOct 23, 13Aug 27, 15[A61K, C07K]
2015/0197,568 CompoundsAbandonedApr 01, 15Jul 16, 15[G01N, C07K]
2015/0005,475 PROCESS FOR REDUCING ANTIBODY AGGREGATE LEVELS AND ANTIBODIES PRODUCED THEREBYAbandonedFeb 01, 13Jan 01, 15[C07K]
2014/0335,081 Treatment For Rheumatoid ArthritisAbandonedOct 10, 12Nov 13, 14[A61K, C07K]
2014/0314,784 ANTI-CXCR4 ANTIBODIES AND METHODS OF USEAbandonedJul 19, 12Oct 23, 14[A61K, C07K]
2014/0302,058 HUMAN ANTI IL-6 ANTIBODIES WITH EXTENDED IN VIVO HALF-LIFE AND THEIR USE IN TREATMENT OF ONCOLOGY, AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASESAbandonedApr 15, 14Oct 09, 14[A61K, C07K]
2014/0127,209 ANTIBODY DERIVATIVESAbandonedMar 08, 13May 08, 14[C07K]
2014/0127,212 Binding Members For IgE MoleculesAbandonedNov 16, 12May 08, 14[C07K]
2014/0030,279 ANTI-CD22 ANTIBODIES AND IMMUNOCONJUGATESAbandonedJul 08, 13Jan 30, 14[A61K]
2014/0023,654 COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLT1 ANTAGONIST FOR TREATING CANCERAbandonedJul 29, 13Jan 23, 14[A61K]
2013/0280,251 Stabilized Angiopoietin-2 Antibodies And Uses ThereofAbandonedJul 01, 13Oct 24, 13[A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.